Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China

被引:10
|
作者
Liu, Y. [1 ]
Sun, Y. [1 ]
Zhang, X. [1 ]
Zhang, Z. [2 ]
Xing, Q. [3 ]
Ren, W. [1 ]
Yao, C. [1 ]
Yu, J. [1 ]
Ding, B. [3 ]
Wang, S. [3 ]
Li, C. [1 ]
机构
[1] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Bacteriol & Immunol,Beijing Key Lab Drug Res, Beijing 101149, Peoples R China
[2] Beijing Changping Ctr TB Control & Prevent, Beijing 102200, Peoples R China
[3] Beijing Res Inst TB Control, Cent Lab, Beijing 100035, Peoples R China
来源
EPIDEMIOLOGY AND INFECTION | 2021年 / 149卷
关键词
Beijing genotype; isoniazid; multidrug-resistant tuberculosis (MDR-TB); Mycobacterium tuberculosis; rifampin; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR CHARACTERISTICS; DRUG-RESISTANCE; ISONIAZID RESISTANCE; KATG; PREVALENCE; MECHANISMS;
D O I
10.1017/S0950268820003131
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The aim of this study was to explore the frequency and distribution of gene mutations that are related to isoniazid (INH) and rifampin (RIF)-resistance in the strains of the multidrug-resistant tuberculosis (MDR-TB) Mycobacterium tuberculosis (M.tb) in Beijing, China. In this retrospective study, the genotypes of 173 MDR-TB strains were analysed by spoligotyping. The katG, inhA genes and the promoter region of inhA, in which genetic mutations confer INH resistance; and the rpoB gene, in which genetic mutations confer RIF resistance, were sequenced. The percentage of resistance-associated nucleotide alterations among the strains of different genotypes was also analysed. In total, 90.8% (157/173) of the MDR strains belonged to the Beijing genotype. Population characteristics were not significantly different among the strains of different genotypes. In total, 50.3% (87/173) strains had mutations at codon S315T of katG; 16.8% (29/173) of strains had mutations in the inhA promoter region; of them, 5.5% (15/173) had point mutations at -15 base (C -> T) of the inhA promoter region. In total, 86.7% (150/173) strains had mutations at rpoB gene; of them, 40% (69/173) strains had mutations at codon S531L of rpoB. The frequency of mutations was not significantly higher in Beijing genotypic MDR strains than in non-Beijing genotypes. Beijing genotypic MDR-TB strains were spreading in Beijing and present a major challenge to TB control in this region. A high prevalence of katG Ser315Thr, inhA promoter region (-15C -> T) and rpoB (S531L) mutations was observed. Molecular diagnostics based on gene mutations was a useful method for rapid detection of MDR-TB in Beijing, China.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
    Skrahina, Alena
    Hurevich, Henadz
    Zalutskaya, Aksana
    Sahalchyk, Evgeni
    Astrauko, Andrei
    Hoffner, Sven
    Rusovich, Valiantsin
    Dadu, Andrei
    de Colombani, Pierpaolo
    Dara, Masoud
    Van Gemert, Wayne
    Zignol, Matteo
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
    Ali, Monadil H.
    Alrasheedy, Alian A.
    Hassali, Mohamed Azmi
    Kibuule, Dan
    Godman, Brian
    ANTIBIOTICS-BASEL, 2019, 8 (03):
  • [3] Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment
    Ormerod, LP
    BRITISH MEDICAL BULLETIN, 2005, 73-74 : 17 - 24
  • [4] New Drugs for the Treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Schaberg, T.
    Otto-Knapp, R.
    Bauer, T.
    PNEUMOLOGIE, 2015, 69 (05): : 282 - 286
  • [5] Multidrug-resistant tuberculosis (MDR-TB) in a BMT recipient.
    Altclas, JD
    Adrian, LO
    Salgueira, CC
    Brennan, VI
    Di Martino, A
    Ritacco, V
    Palmero, D
    BLOOD, 2003, 102 (11) : 445B - 445B
  • [6] Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
    Satria A. Prabowo
    Matthias I. Gröschel
    Ed D. L. Schmidt
    Alena Skrahina
    Traian Mihaescu
    Serap Hastürk
    Rotislav Mitrofanov
    Edita Pimkina
    Ildikó Visontai
    Bouke de Jong
    John L. Stanford
    Père-Joan Cardona
    Stefan H. E. Kaufmann
    Tjip S. van der Werf
    Medical Microbiology and Immunology, 2013, 202 : 95 - 104
  • [7] Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
    Prabowo, Satria A.
    Groeschel, Matthias I.
    Schmidt, Ed D. L.
    Skrahina, Alena
    Mihaescu, Traian
    Hasturk, Serap
    Mitrofanov, Rotislav
    Pimkina, Edita
    Visontai, Ildik
    de Jong, Bouke
    Stanford, John L.
    Cardona, Pere-Joan
    Kaufmann, Stefan H. E.
    Werf, Tjip S. van der
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2013, 202 (02) : 95 - 104
  • [8] Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
    Taylor, Holly A.
    Dowdy, David W.
    Searle, Alexandra R.
    Stennett, Andrea L.
    Dukhanin, Vadim
    Zwerling, Alice A.
    Merritt, Maria W.
    SSM-QUALITATIVE RESEARCH IN HEALTH, 2022, 2
  • [9] New projects for rapid diagnosis of multidrug-resistant tuberculosis (MDR-TB)
    Desikan, Prabha
    NATIONAL MEDICAL JOURNAL OF INDIA, 2008, 21 (04): : 211 - 212
  • [10] The global risk of dying from multidrug-resistant tuberculosis (MDR-TB)
    Brondi, Luciana
    Falzon, Dennis
    Sismanidis, Charalambos
    Glaziou, Philippe
    Zignol, Matteo
    Floyd, Katherine
    Campbell, Harry
    Nair, Harish
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44